Roberto Gonzalez-Salinas1, Manuel Garza-Leon2, Manuel Saenz-de-Viteri3, Juan C Solis-S4, Rosario Gulias-Cañizo5,6, Hugo Quiroz-Mercado7. 1. Research Department, Hospital Luis Sánchez Bulnes, Asociación para Evitar la Ceguera en México I.A.P., Vicente García Torres 46, Barrio San Lucas, Coyoacán, 04030, Mexico City, Mexico. dr.gonzalezsalinas@gmail.com. 2. Dirección de Ciencias Médicas de la División de Ciencias de la Salud, Universidad de Monterrey, Monterrey, Nuevo León, Mexico. 3. Department of Ophthalmology, Universidad de Navarra, Pamplona, Spain. 4. Biomedical Research Department, Universidad Autónoma de Querétaro, 76170, Querétaro, Mexico. 5. Research Department, Hospital Luis Sánchez Bulnes, Asociación para Evitar la Ceguera en México I.A.P., Vicente García Torres 46, Barrio San Lucas, Coyoacán, 04030, Mexico City, Mexico. 6. Centro de Investigación y Estudios Avanzados, I.P.N. (CINVESTAV), 07360, Mexico City, Mexico. 7. University of Colorado, Denver, CO, USA.
Abstract
PURPOSE: To compare the cumulative dissipated energy (CDE), aspiration time and estimated aspiration fluid utilized during phacoemulsification cataract surgery using two phacoemulsification systems . METHODS: A total of 164 consecutive eyes of 164 patients undergoing cataract surgery, 82 in the active-fluidics group and 82 in the gravity-fluidics group were enrolled in this study. Cataracts graded NII to NIII using LOCS II were included. Each subject was randomly assigned to one of the two platforms with a specific configuration: the active-fluidics Centurion ® phacoemulsification system or the gravity-fluidics Infiniti ® Vision System. CDE, aspiration time (AT) and the mean estimated aspiration fluid (EAF) were registered and compared. RESULTS:A mean age of 68.3 ± 9.8 years was found (range 57-92 years), and no significant difference was evident between both groups. A positive correlation between the CDE values obtained by both platforms was verified (r = 0.271, R 2 = 0.073, P = 0.013). Similarly, a significant correlation was evidenced for the EAF (r = 0.334, R 2 = 0.112, P = 0.046) and AT values (r = 0.156, R 2 = 0.024, P = 0.161). A statistically significantly lower CDE count, aspiration time and estimated fluid were obtained using the active-fluidics configuration when compared to the gravity-fluidics configuration by 19.29, 12.10 and 9.29%, respectively (P = 0.001, P < 0.0001 and P = 0.001). CONCLUSIONS: The active-fluidics Centurion ® phacoemulsification system achieved higher surgical efficiency than the gravity-fluidics Infiniti ® IP system for NII and NIII cataracts.
RCT Entities:
PURPOSE: To compare the cumulative dissipated energy (CDE), aspiration time and estimated aspiration fluid utilized during phacoemulsification cataract surgery using two phacoemulsification systems . METHODS: A total of 164 consecutive eyes of 164 patients undergoing cataract surgery, 82 in the active-fluidics group and 82 in the gravity-fluidics group were enrolled in this study. Cataracts graded NII to NIII using LOCS II were included. Each subject was randomly assigned to one of the two platforms with a specific configuration: the active-fluidics Centurion ® phacoemulsification system or the gravity-fluidics Infiniti ® Vision System. CDE, aspiration time (AT) and the mean estimated aspiration fluid (EAF) were registered and compared. RESULTS: A mean age of 68.3 ± 9.8 years was found (range 57-92 years), and no significant difference was evident between both groups. A positive correlation between the CDE values obtained by both platforms was verified (r = 0.271, R 2 = 0.073, P = 0.013). Similarly, a significant correlation was evidenced for the EAF (r = 0.334, R 2 = 0.112, P = 0.046) and AT values (r = 0.156, R 2 = 0.024, P = 0.161). A statistically significantly lower CDE count, aspiration time and estimated fluid were obtained using the active-fluidics configuration when compared to the gravity-fluidics configuration by 19.29, 12.10 and 9.29%, respectively (P = 0.001, P < 0.0001 and P = 0.001). CONCLUSIONS: The active-fluidics Centurion ® phacoemulsification system achieved higher surgical efficiency than the gravity-fluidics Infiniti ® IP system for NII and NIII cataracts.
Authors: Mark Packer; William J Fishkind; I Howard Fine; Barry S Seibel; Richard S Hoffman Journal: J Cataract Refract Surg Date: 2005-02 Impact factor: 3.351
Authors: William Hodge; Tanya Horsley; David Albiani; Julia Baryla; Michel Belliveau; Ralf Buhrmann; Michael O'Connor; Jason Blair; Elizabeth Lowcock Journal: CMAJ Date: 2007-04-24 Impact factor: 8.262
Authors: Gabriel Quesada; Daniel H Chang; Kevin L Waltz; Andrew A Kao; Rodrigo Quesada; Ying Wang; Leilei Ji; Dari Parizadeh; Luis Atiles Journal: Clin Ophthalmol Date: 2022-08-06